Damora Therapeutics (DMRA) Other Working Capital Changes (2019 - 2026)
Damora Therapeutics (DMRA) posted Other Working Capital Changes of -$290000.0 for Q1 2026, down 5700.0% on a QoQ basis from -$5000.0 in Q4 2025, and down 189.78% year-over-year from $323000.0 in Q1 2025.
Damora Therapeutics (DMRA) Other Working Capital Changes (2019 - 2026) Analysis & Trends
Damora Therapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$290000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 1700.0% year-over-year to -$54000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66000.0 (changed N/A YoY) and the FY2025 annual result came in at -$15000.0, down 134.88% from the prior year.
- Other Working Capital Changes was -$54000.0 for Q1 2026 at Damora Therapeutics, down from -$21000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $8000.0 in Q2 2025 and bottomed at -$54000.0 in Q1 2026.
- A 5-year average of -$94294.1 and a median of -$92000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 647.89% — and 2024, when it surged 820.28%.
- Damora Therapeutics' Other Working Capital Changes stood at -$21000.0 in 2025, then plunged by 157.14% to -$54000.0 in 2026.
- Business Quant data shows DMRA's Other Working Capital Changes at -$54000.0 in Q1 2026, -$21000.0 in Q4 2025, and $1000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -290,000.00 |
| Mar 31, 2026 | -290,000.00 |
| Mar 31, 2026 | -290,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Jun 30, 2025 | -333,000.00 |
| Jun 30, 2025 | -333,000.00 |
| Jun 30, 2025 | -333,000.00 |
| Mar 31, 2025 | 323,000.00 |
| Mar 31, 2025 | 323,000.00 |
| Mar 31, 2025 | 323,000.00 |
| Dec 31, 2024 | 1.95 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | -1.95 Mn |
| Sep 30, 2024 | -1.95 Mn |